The Future of Paediatric Heart Interventions: Where Will We Be in 2030?

Tomohito Kogure1,2, Shakeel A Qureshi3

  • 1Department of Congenital Cardiology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.

Insights

Advancements in pediatric heart interventions, including biodegradable stents and MRI-guided procedures, show promise for the next decade. Ongoing innovation in cardiac catheterization techniques and devices will improve congenital heart disease treatment.

Area of Science:

  • Interventional Cardiology
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • Congenital heart disease treatments have seen rapid advancements in catheterization therapies over the past 30 years.
  • Both technical innovations and device development have contributed to improved patient outcomes worldwide.

Purpose of the Study:

  • To review the current status of novel devices and techniques in pediatric heart intervention.
  • To discuss future trends and likely developments in the next decade of pediatric cardiac interventions.

Main Methods:

  • Review of recent technological innovations and device developments in cardiac catheterization.
  • Analysis of emerging trends and their potential impact on pediatric heart interventions.

Main Results:

  • Biodegradable stents and devices show significant progress.
  • Transcatheter pulmonary valve implantation demonstrates promising early results.
  • MRI-guided interventions are advancing rapidly with positive outcomes.

Conclusions:

  • Paediatric heart intervention is poised for significant growth in the next decade.
  • Emerging technologies like biodegradable stents and MRI-guided procedures are expected to become widespread.
  • Continued technological progress ensures a promising future for treating congenital heart disease in children.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
140
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
122